Published in JAMA on June 14, 2000
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA (2006) 2.35
Research in action: using positive deviance to improve quality of health care. Implement Sci (2009) 2.26
Factors associated with poorer prognosis for patients undergoing primary percutaneous coronary intervention during off-hours: biology or systems failure? JACC Cardiovasc Interv (2008) 2.22
Access to emergency care in the United States. Ann Emerg Med (2009) 2.19
Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet (2014) 1.70
Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol (2005) 1.69
Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med (2008) 1.59
Accuracy of prehospital transport time estimation. Acad Emerg Med (2014) 1.56
Expansion of invasive cardiac services in the United States. Circulation (2013) 1.54
Three simple rules to ensure reasonably credible subgroup analyses. BMJ (2015) 1.40
Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol (2009) 1.40
Door-to-balloon time in primary percutaneous coronary intervention predicts degree of myocardial necrosis as measured using cardiac biomarkers. Tex Heart Inst J (2010) 1.39
Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit. CMAJ (2003) 1.39
TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm (2010) 1.32
Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27
Percutaneous coronary intervention: recommendations for good practice and training. Heart (2005) 1.14
Monitoring guideline adherence in the management of acute coronary syndrome in hospitals: design of a multicentre study. Neth Heart J (2014) 1.14
Acute myocardial infarction system of care in the third world. Neth Heart J (2012) 1.13
Expedited transfer for primary percutaneous coronary intervention: a program evaluation. CMAJ (2007) 1.13
Effects of Door-to-Balloon Times on Outcomes in Taiwanese Patients Receiving Primary Percutaneous Coronary Intervention: A Report of Taiwan Acute Coronary Syndrome Full Spectrum Registry. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 1.10
Primary coronary angioplasty for ST-Elevation Myocardial Infarction in Qatar: First nationwide program. Glob Cardiol Sci Pract (2013) 1.08
Delay in presentation and reperfusion therapy in ST-elevation myocardial infarction. Am J Med (2008) 1.04
Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler Thromb Vasc Biol (2011) 1.02
Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation. Basic Res Cardiol (2011) 1.00
Primary angioplasty should be first line treatment for acute myocardial infarction: AGAINST. BMJ (2004) 0.98
Frequency and predictors of urgent coronary angiography in patients with acute pericarditis. Mayo Clin Proc (2009) 0.98
Is primary angioplasty for some as good as primary angioplasty for all? J Gen Intern Med (2002) 0.98
Door-to-puncture: a practical metric for capturing and enhancing system processes associated with endovascular stroke care, preliminary results from the rapid reperfusion registry. J Am Heart Assoc (2014) 0.95
Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort. Heart Vessels (2016) 0.95
Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology. Int J Cardiovasc Imaging (2010) 0.94
The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea acute myocardial infarction registry. J Korean Med Sci (2008) 0.93
Acute coronary syndromes: Diagnosis and management, part II. Mayo Clin Proc (2009) 0.93
New Right Bundle Branch Block as a Criterion for Emergent Coronary Angiography. N Am J Med Sci (2015) 0.91
Use of the prehospital ECG improves door-to-balloon times in ST segment elevation myocardial infarction irrespective of time of day or day of week. Emerg Med J (2007) 0.90
A review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarction. J Gen Intern Med (2008) 0.90
Factors related to prehospital time delay in acute ST-segment elevation myocardial infarction. J Korean Med Sci (2012) 0.90
Culprit-vessel percutaneous coronary intervention followed by contralateral angiography versus complete angiography in patients with ST-elevation myocardial infarction. Tex Heart Inst J (2012) 0.90
Quality measure study: progress in reducing the door-to-balloon time in patients with ST-segment elevation myocardial infarction. Hawaii Med J (2010) 0.89
Timely and optimal treatment of patients with STEMI. Nat Rev Cardiol (2012) 0.89
The telecardiology revolution: improving the management of cardiac disease in primary care. J R Soc Med (2010) 0.88
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J (2010) 0.88
Beyond Measurement and Reward: Methods of Motivating Quality Improvement and Accountability. Health Serv Res (2015) 0.88
Impact of minimising door-to-balloon times in ST-elevation myocardial infarction to less than 30 min on outcome: an analysis over an 8-year period in a tertiary care centre. Clin Res Cardiol (2010) 0.88
Primary percutaneous intervention of ST-elevation myocardial infarction in Austria: Results from the Austrian acute PCI registry 2005-2007. Wien Klin Wochenschr (2010) 0.87
The safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial. BMJ Open (2013) 0.87
Renal impairment according to acute kidney injury network criteria among ST elevation myocardial infarction patients undergoing primary percutaneous intervention: a retrospective observational study. Clin Res Cardiol (2014) 0.86
The door-to-balloon alliance for quality: who joins national collaborative efforts and why? Jt Comm J Qual Patient Saf (2009) 0.86
Data quality issues impede comparability of hospital treatment delay performance indicators. Neth Heart J (2015) 0.85
A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals. Can J Cardiol (2008) 0.85
Delay from first medical contact to primary PCI and all-cause mortality: a nationwide study of patients with ST-elevation myocardial infarction. J Am Heart Assoc (2014) 0.85
The impact of circadian variation on 12-month mortality in patients with acute myocardial infarction. Korean Circ J (2010) 0.85
Timeliness of interfacility transfer for ED patients with ST-elevation myocardial infarction. Am J Emerg Med (2015) 0.85
Manual versus nonmanual thrombectomy in primary and rescue percutaneous coronary angioplasty. Heart Vessels (2010) 0.83
Primary percutaneous coronary intervention in acute myocardial infarction: time, time, and time! Heart (2005) 0.82
Myocardial infarction centres: the way forward. Heart (2005) 0.82
Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart (2004) 0.82
Outcomes of angioplasty vs thrombolysis by hospital angioplasty volume. JAMA (2001) 0.81
Primary PCI during off-hours is not related to increased mortality. Eur Heart J Acute Cardiovasc Care (2012) 0.81
Revascularization and cardioprotective drug treatment in myocardial infarction patients: how do they impact on patients' survival when delivered as usual care. BMC Cardiovasc Disord (2006) 0.81
Outcomes of after-hours versus regular working hours primary percutaneous coronary intervention for acute myocardial infarction. BMJ Qual Saf (2011) 0.81
Temporal trends of system of care for STEMI: insights from the Jakarta Cardiovascular Care Unit Network System. PLoS One (2014) 0.81
Time delay in primary angioplasty: how relevant is it? Heart (2007) 0.81
Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry. Heart (2005) 0.81
Hydrogen Sulfide Targets the Cys320/Cys529 Motif in Kv4.2 to Inhibit the Ito Potassium Channels in Cardiomyocytes and Regularizes Fatal Arrhythmia in Myocardial Infarction. Antioxid Redox Signal (2015) 0.81
Timely reperfusion for ST-segment elevation myocardial infarction: Effect of direct transfer to primary angioplasty on time delays and clinical outcomes. World J Cardiol (2014) 0.80
Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J Am Heart Assoc (2013) 0.80
The effects of facilitated primary PCI by guide wire on procedural and clinical outcomes in acute ST-segment elevation myocardial infarction. Clin Res Cardiol (2007) 0.80
Longitudinal peak strain detects a smaller risk area than visual assessment of wall motion in acute myocardial infarction. Cardiovasc Ultrasound (2010) 0.80
Implementation of multiple strategies for improved door-to-balloon time in patients with ST-segment elevation myocardial infarction. Heart Vessels (2013) 0.80
An artificial neural network to safely reduce the number of ambulance ECGs transmitted for physician assessment in a system with prehospital detection of ST elevation myocardial infarction. Scand J Trauma Resusc Emerg Med (2012) 0.80
Primary angioplasty: preprocedural pharmacological therapy. Neth Heart J (2006) 0.80
Symptom-to-door time in ST segment elevation myocardial infarction: overemphasized or overlooked? Results from the AMI-McGill study. Can J Cardiol (2008) 0.80
Cause of Emergency Department Mortality; a Case-control Study. Emerg (Tehran) (2014) 0.79
Primary angioplasty--time is of the essence. JAMA (2000) 0.79
Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis. Ont Health Technol Assess Ser (2004) 0.79
The relationship between the emergent primary percutaneous coronary intervention quality measure and inpatient myocardial infarction mortality. Acad Emerg Med (2010) 0.79
Changes in mortality on weekend versus weekday admissions for Acute Coronary Syndrome in the United States over the past decade. Int J Cardiol (2016) 0.78
Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI. BMC Cardiovasc Disord (2012) 0.78
Should patients with acute ST elevation MI be transferred for primary PCI? Heart (2004) 0.78
Trends in treatment delays for patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. BMC Cardiovasc Disord (2014) 0.78
Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart (2004) 0.78
Performance of reperfusion therapy and hospital mortality in ST-elevation myocardial infarction patients with non-chest pain complaints. Yonsei Med J (2014) 0.78
Unique transcriptional profile of sustained ligand-activated preconditioning in pre- and post-ischemic myocardium. PLoS One (2013) 0.78
The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE. Basic Res Cardiol (2016) 0.78
Debate: Should the elderly receive thrombolytic therapy or primary angioplasty? Curr Control Trials Cardiovasc Med (2000) 0.77
Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report. Can J Cardiol (2006) 0.77
Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions. Neth Heart J (2011) 0.77
Effect of cardiogenic shock hospital volume on mortality in patients with cardiogenic shock. J Am Heart Assoc (2015) 0.77
Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction. Scientifica (Cairo) (2012) 0.77
Thrombolysis in the age of Primary Percutaneous Coronary Intervention: Mini-Review and Meta-analysis of Early PCI. Int J Health Sci (Qassim) (2013) 0.77
Predictors of Delay in Seeking Health Care among Myocardial Infarction Patients, Minia District, Egypt. Adv Prev Med (2015) 0.77
Regional functional recovery after acute myocardial infarction: a cardiac magnetic resonance long-term study. Int J Cardiovasc Imaging (2011) 0.77
Organizational resiliency: how top-performing hospitals respond to setbacks in improving quality of cardiac care. J Healthc Manag (2008) 0.77
Randomized comparative study of left versus right radial approach in the setting of primary percutaneous coronary intervention for ST-elevation myocardial infarction. Clin Interv Aging (2015) 0.76
Acute myocardial infarction: the case for pre-hospital thrombolysis with or without percutaneous coronary intervention. Heart (2005) 0.76
The Tradeoff between Travel Time from Home to Hospital and Door to Balloon Time in Determining Mortality among STEMI Patients Undergoing PCI. PLoS One (2016) 0.76
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med (2001) 9.31
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. Radiology (1988) 7.26
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med (2001) 5.05
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
The somatic replication of DNA methylation. Cell (1981) 4.42
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med (1995) 4.29
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1999) 4.15
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA (1993) 4.01
A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 4.00
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76
Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol (2000) 3.67
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66
Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation (1993) 3.31
A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J (1998) 3.27
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol (1998) 3.16
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial. Lancet (2009) 3.13
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA (2000) 3.12
The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. N Engl J Med (1993) 3.12
Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med (1997) 3.12
Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92
Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86
Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. N Engl J Med (1996) 2.83
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol (1996) 2.81
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med (1998) 2.80
The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol (1999) 2.79
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76
A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med (1996) 2.73
Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med (1997) 2.65
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol (1996) 2.60
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med (2000) 2.57
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57
Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54
Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation (1994) 2.53
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol (1999) 2.51
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim Biophys Acta (1995) 2.47
Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med (1999) 2.46
Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum (1998) 2.45